Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease

Conditions: Adult Congenital Heart Disease; Heart Failure Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Sponsors: Anita Saraf; The Pittsburgh Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials